XBIO XENETIC BIOSCIENCES INC Company Mergers 8-K Filing 2024 - Research Agreement Extension Xenetic Biosciences has extended its research agreement with The Scripps Research Institute for an additional year and will provide up to $400,000 in funding for ongoing research on its DNase oncology technology, with initial payments of about $65,000 starting immediately.Get access to all SEC 8-K filings of the XENETIC BIOSCIENCES INC